You are here: Industry Insights > GSK

News List

Another Giant Entering, the TIGIT Antibody Market is Highly Competitive PharmaSources/Dopine
July 09, 2021
GlaxoSmithKline (GSK) and iteos Therapeutics have announced a collaboration to jointly develop and commercialize EOS-448. EOS-448 is an anti-TIGIT monoclonal antibody, which is in the phase I development.
GSK’s top scientist to quit, become CEO of anti-ageing start-up Pharmaceutical-Technology
January 20, 2022
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
GSK rejects Unilever’s $68.4bn offer for Consumer Healthcare business Pharmaceutical-Technology
January 18, 2022
GSK noted that the bids ‘fundamentally undervalued’ the Consumer Healthcare business.
GSK Singapore announces availability of Shingrix in Singapore for shingles prevention prnasia
January 10, 2022
GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore.
Third Former GlaxoSmithKline Scientist Pleads Guilty to Stealing Trade Secrets to Benefit Chinese Pharma Company FirstWordPharma
January 04, 2022
United States Attorney Jennifer Arbittier Williams announced that Lucy Xi, 44, formerly a resident of Malvern, PA, pleaded guilty to conspiracy to steal trade secrets from GlaxoSmithKline (GSK) to benefit a Chinese pharmaceutical company named Renopharma.
EC grants marketing authorisation to GSK-Vir’s Xevudy for Covid-19 Pharmaceutical-Technology
December 21, 2021
The European Commission (EC) has granted marketing authorisation to GlaxoSmithKline (GSK) and Vir Biotechnology’s Xevudy (sotrovimab) to treat Covid-19 in the early stage.
GSK Singapore Announces Additional Supply of Monoclonal Antibody Sotrovimab to the Government of Singapore prnasia
December 07, 2021
GlaxoSmithKline Singapore announced an agreement with the Government of Singapore to supply additional doses of sotrovimab. Sotrovimab is an investigational single-dose monoclonal antibody developed in partnership...
GSK to provide malaria vaccines for Gavi eligible countries PharmaTimes
December 06, 2021
The new development will arm healthcare providers with a vital tool to address the steep rise of malaria cases in children living in Africa.
GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease WorldPharmaNews
December 06, 2021
GlaxoSmithKline plc and the University of Oxford announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine. The new Institute, which will be based at the University of Oxford, aims to...
GSK and Oxford University announce Oxford-GSK Institute of Molecular and Computational Medicine expresspharma
December 03, 2021
The institute aims to improve the success and speed of research and development of new medicines, building on insights from human genetics and using advanced technologies such as functional genomics and machine learning.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page